Exchange expands derivatives lineup to meet investor hedging demand after record turnover this year Hong Kong Exchanges and Clearing (HKEX) will launch five new weekly stock options and a Hang Seng ...
Stockhead on MSN
Health Kick Podcast: Cynata Therapeutics entering into major stem cell clinical catalysts
Tim Boreham catches up with Cynata Therapeutics CEO Dr Kilian Kelly to talk the stem cell industry as the company ... Read ...
Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback